nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—ADRA2C—attention deficit hyperactivity disorder	0.365	0.463	CbGaD
Oxymetazoline—HTR1B—attention deficit hyperactivity disorder	0.176	0.223	CbGaD
Oxymetazoline—ADRA2A—attention deficit hyperactivity disorder	0.156	0.198	CbGaD
Oxymetazoline—HTR2A—attention deficit hyperactivity disorder	0.0914	0.116	CbGaD
Oxymetazoline—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00432	0.0933	CbGeAlD
Oxymetazoline—Xylometazoline—ADRA2C—attention deficit hyperactivity disorder	0.00364	0.524	CrCbGaD
Oxymetazoline—HTR1E—forebrain—attention deficit hyperactivity disorder	0.00235	0.0508	CbGeAlD
Oxymetazoline—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00229	0.0496	CbGeAlD
Oxymetazoline—Xylometazoline—HTR1B—attention deficit hyperactivity disorder	0.00176	0.252	CrCbGaD
Oxymetazoline—Xylometazoline—ADRA2A—attention deficit hyperactivity disorder	0.00155	0.224	CrCbGaD
Oxymetazoline—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.00144	0.0311	CbGeAlD
Oxymetazoline—HTR1E—nervous system—attention deficit hyperactivity disorder	0.00128	0.0276	CbGeAlD
Oxymetazoline—HTR1E—central nervous system—attention deficit hyperactivity disorder	0.00123	0.0265	CbGeAlD
Oxymetazoline—NISCH—midbrain—attention deficit hyperactivity disorder	0.00114	0.0246	CbGeAlD
Oxymetazoline—HTR1B—forebrain—attention deficit hyperactivity disorder	0.00111	0.024	CbGeAlD
Oxymetazoline—HTR1D—forebrain—attention deficit hyperactivity disorder	0.00108	0.0233	CbGeAlD
Oxymetazoline—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00107	0.023	CbGeAlD
Oxymetazoline—HTR2B—forebrain—attention deficit hyperactivity disorder	0.001	0.0216	CbGeAlD
Oxymetazoline—HTR1E—brain—attention deficit hyperactivity disorder	0.000975	0.0211	CbGeAlD
Oxymetazoline—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.00094	0.0203	CbGeAlD
Oxymetazoline—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.00091	0.0197	CbGeAlD
Oxymetazoline—NISCH—cerebellum—attention deficit hyperactivity disorder	0.000881	0.019	CbGeAlD
Oxymetazoline—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.000847	0.0183	CbGeAlD
Oxymetazoline—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000827	0.0179	CbGeAlD
Oxymetazoline—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000799	0.0173	CbGeAlD
Oxymetazoline—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.000782	0.0169	CbGeAlD
Oxymetazoline—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000769	0.0166	CbGeAlD
Oxymetazoline—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.000753	0.0163	CbGeAlD
Oxymetazoline—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000734	0.0159	CbGeAlD
Oxymetazoline—NISCH—brain—attention deficit hyperactivity disorder	0.000716	0.0155	CbGeAlD
Oxymetazoline—HTR1D—midbrain—attention deficit hyperactivity disorder	0.000711	0.0154	CbGeAlD
Oxymetazoline—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000704	0.0152	CbGeAlD
Oxymetazoline—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000699	0.0151	CbGeAlD
Oxymetazoline—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000629	0.0136	CbGeAlD
Oxymetazoline—ADRA1B—brain—attention deficit hyperactivity disorder	0.000611	0.0132	CbGeAlD
Oxymetazoline—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000604	0.013	CbGeAlD
Oxymetazoline—ADRA1D—brain—attention deficit hyperactivity disorder	0.000598	0.0129	CbGeAlD
Oxymetazoline—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000584	0.0126	CbGeAlD
Oxymetazoline—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000581	0.0126	CbGeAlD
Oxymetazoline—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000579	0.0125	CbGeAlD
Oxymetazoline—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000563	0.0122	CbGeAlD
Oxymetazoline—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000557	0.012	CbGeAlD
Oxymetazoline—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000544	0.0117	CbGeAlD
Oxymetazoline—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000535	0.0115	CbGeAlD
Oxymetazoline—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000523	0.0113	CbGeAlD
Oxymetazoline—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.00052	0.0112	CbGeAlD
Oxymetazoline—HTR1B—brain—attention deficit hyperactivity disorder	0.000461	0.00997	CbGeAlD
Oxymetazoline—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000452	0.00977	CbGeAlD
Oxymetazoline—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000449	0.0097	CbGeAlD
Oxymetazoline—HTR1D—brain—attention deficit hyperactivity disorder	0.000447	0.00965	CbGeAlD
Oxymetazoline—HTR2C—brain—attention deficit hyperactivity disorder	0.000442	0.00955	CbGeAlD
Oxymetazoline—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000432	0.00934	CbGeAlD
Oxymetazoline—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000428	0.00924	CbGeAlD
Oxymetazoline—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000423	0.00913	CbGeAlD
Oxymetazoline—HTR2B—brain—attention deficit hyperactivity disorder	0.000415	0.00897	CbGeAlD
Oxymetazoline—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000415	0.00897	CbGeAlD
Oxymetazoline—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000412	0.0089	CbGeAlD
Oxymetazoline—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000403	0.0087	CbGeAlD
Oxymetazoline—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000353	0.00763	CbGeAlD
Oxymetazoline—ADRA1A—brain—attention deficit hyperactivity disorder	0.000343	0.00741	CbGeAlD
Oxymetazoline—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000341	0.00737	CbGeAlD
Oxymetazoline—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000329	0.0071	CbGeAlD
Oxymetazoline—ADRA2C—brain—attention deficit hyperactivity disorder	0.000327	0.00706	CbGeAlD
Oxymetazoline—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000321	0.00694	CbGeAlD
Oxymetazoline—HTR2A—nervous system—attention deficit hyperactivity disorder	0.00029	0.00627	CbGeAlD
Oxymetazoline—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000279	0.00604	CbGeAlD
Oxymetazoline—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000273	0.0059	CbGeAlD
Oxymetazoline—ADRA2A—brain—attention deficit hyperactivity disorder	0.000261	0.00564	CbGeAlD
Oxymetazoline—HTR2A—brain—attention deficit hyperactivity disorder	0.000222	0.00479	CbGeAlD
Oxymetazoline—ADRA1D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.13e-05	0.000135	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.13e-05	0.000135	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.11e-05	0.000134	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.11e-05	0.000133	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.1e-05	0.000133	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.09e-05	0.000132	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.09e-05	0.000132	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.08e-05	0.000132	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.08e-05	0.000131	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.07e-05	0.000131	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.06e-05	0.000131	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.06e-05	0.00013	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.05e-05	0.00013	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.05e-05	0.00013	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	2.05e-05	0.00013	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.05e-05	0.00013	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.05e-05	0.000129	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.04e-05	0.000129	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.03e-05	0.000128	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.02e-05	0.000128	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.01e-05	0.000127	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.01e-05	0.000127	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2e-05	0.000127	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2e-05	0.000127	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.99e-05	0.000126	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.99e-05	0.000126	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.98e-05	0.000125	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.97e-05	0.000125	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.97e-05	0.000125	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.97e-05	0.000125	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.97e-05	0.000125	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.96e-05	0.000124	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.95e-05	0.000124	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.95e-05	0.000124	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.95e-05	0.000124	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	1.95e-05	0.000123	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.94e-05	0.000123	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.93e-05	0.000122	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.93e-05	0.000122	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.93e-05	0.000122	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.93e-05	0.000122	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.92e-05	0.000122	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.92e-05	0.000122	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.92e-05	0.000122	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.92e-05	0.000121	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.91e-05	0.000121	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.9e-05	0.00012	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.9e-05	0.00012	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.89e-05	0.000119	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	1.88e-05	0.000119	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.88e-05	0.000119	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.87e-05	0.000119	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.86e-05	0.000118	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	1.86e-05	0.000118	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.85e-05	0.000117	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.85e-05	0.000117	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.84e-05	0.000116	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.83e-05	0.000116	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.83e-05	0.000116	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.82e-05	0.000115	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	1.81e-05	0.000114	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.8e-05	0.000114	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.8e-05	0.000114	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.8e-05	0.000114	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.79e-05	0.000113	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.79e-05	0.000113	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.79e-05	0.000113	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.78e-05	0.000113	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.78e-05	0.000112	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.77e-05	0.000112	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.77e-05	0.000112	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.77e-05	0.000112	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.75e-05	0.000111	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.75e-05	0.000111	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.75e-05	0.000111	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.74e-05	0.00011	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.74e-05	0.00011	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.74e-05	0.00011	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.74e-05	0.00011	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.74e-05	0.00011	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.74e-05	0.00011	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.73e-05	0.000109	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.72e-05	0.000109	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.72e-05	0.000109	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.71e-05	0.000108	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.71e-05	0.000108	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.71e-05	0.000108	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.71e-05	0.000108	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.69e-05	0.000107	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.68e-05	0.000106	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.67e-05	0.000106	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.67e-05	0.000105	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.66e-05	0.000105	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	1.65e-05	0.000104	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.65e-05	0.000104	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.64e-05	0.000104	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.63e-05	0.000103	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.63e-05	0.000103	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.63e-05	0.000103	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.62e-05	0.000102	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	1.62e-05	0.000102	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.61e-05	0.000102	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.61e-05	0.000102	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.61e-05	0.000102	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.61e-05	0.000102	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.6e-05	0.000101	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.6e-05	0.000101	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.59e-05	0.0001	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.58e-05	0.0001	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.58e-05	0.0001	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.58e-05	9.98e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.57e-05	9.94e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.57e-05	9.91e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.56e-05	9.89e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.56e-05	9.85e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.55e-05	9.81e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.55e-05	9.81e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.53e-05	9.69e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.52e-05	9.65e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.51e-05	9.57e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.51e-05	9.54e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.51e-05	9.53e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.49e-05	9.45e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.49e-05	9.44e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.48e-05	9.34e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.46e-05	9.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.46e-05	9.23e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.46e-05	9.22e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.46e-05	9.21e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.45e-05	9.18e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.45e-05	9.17e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.45e-05	9.15e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.43e-05	9.07e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.43e-05	9.02e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.42e-05	9e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.42e-05	8.99e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.4e-05	8.88e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.4e-05	8.88e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.4e-05	8.87e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.39e-05	8.81e-05	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.38e-05	8.73e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.36e-05	8.59e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.35e-05	8.57e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.35e-05	8.57e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.35e-05	8.52e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	1.34e-05	8.46e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.34e-05	8.46e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.33e-05	8.45e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.33e-05	8.45e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.33e-05	8.43e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.32e-05	8.38e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.32e-05	8.34e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.32e-05	8.33e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	1.32e-05	8.32e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.31e-05	8.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.3e-05	8.26e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.29e-05	8.19e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.27e-05	8.02e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.26e-05	8e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.26e-05	7.96e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.25e-05	7.93e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.24e-05	7.86e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.24e-05	7.84e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.23e-05	7.77e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.23e-05	7.76e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.22e-05	7.74e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.22e-05	7.74e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.22e-05	7.7e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.21e-05	7.65e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.18e-05	7.49e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.18e-05	7.49e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.18e-05	7.45e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.17e-05	7.43e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.16e-05	7.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.14e-05	7.23e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.14e-05	7.23e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.14e-05	7.22e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.13e-05	7.16e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	1.13e-05	7.15e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.12e-05	7.12e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	7.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.11e-05	7.01e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.1e-05	6.96e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.1e-05	6.96e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.1e-05	6.96e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.1e-05	6.93e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.08e-05	6.85e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.08e-05	6.81e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.07e-05	6.76e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.07e-05	6.74e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.06e-05	6.73e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.06e-05	6.69e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	1.05e-05	6.67e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.05e-05	6.64e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.05e-05	6.63e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.03e-05	6.55e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.03e-05	6.55e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.03e-05	6.53e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.03e-05	6.52e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.02e-05	6.47e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.02e-05	6.44e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.99e-06	6.32e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	9.97e-06	6.31e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.91e-06	6.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	9.9e-06	6.27e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.82e-06	6.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.64e-06	6.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.62e-06	6.09e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.61e-06	6.08e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.51e-06	6.02e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.48e-06	6e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.35e-06	5.92e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.35e-06	5.92e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.31e-06	5.89e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.28e-06	5.87e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.23e-06	5.84e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.16e-06	5.79e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.16e-06	5.79e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.04e-06	5.72e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.94e-06	5.66e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.65e-06	5.48e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.6e-06	5.44e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.6e-06	5.44e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	8.57e-06	5.42e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.42e-06	5.33e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.4e-06	5.32e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	8.1e-06	5.13e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	8.04e-06	5.09e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8e-06	5.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.83e-06	4.95e-05	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.31e-06	4.62e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.22e-06	4.57e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.94e-06	4.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.75e-06	4.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.64e-06	4.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.9e-06	3.73e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.48e-06	3.47e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.95e-06	3.14e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.85e-06	3.07e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.56e-06	2.88e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	4.28e-06	2.71e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.24e-06	2.68e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.83e-06	2.42e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.68e-06	2.33e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.58e-06	2.26e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.52e-06	2.23e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	3.47e-06	2.2e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.19e-06	2.02e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.13e-06	1.98e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.9e-06	1.84e-05	CbGpPWpGaD
